SCHEMBL24027318

SCHEMBL24027318

CC(C)c1ccc2[nH]c(CSC(C)(C)C)nc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.36
▸ LMNA P02545 1/20 0.36
▸ RAB9A P51151 4/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2D6 P10635 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP2C19 P33261 2/20 0.35
▸ ALDH1A1 P00352 2/20 0.35
▸ HPGD P15428 1/20 0.35
▸ KIF11 P52732 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ GAA P10253 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ THRB P10828 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SCN10A Q9Y5Y9 1/20 0.35
▸ CYP2E1 P05181 1/20 0.34
▸ CYP2C8 P10632 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20644584 0.81 MAPT (0.38) SMN1; SMN2LMNARAB9ANPC1CYP1A2
SCHEMBL10299138 0.79 DDAH1 (0.54) RAB9AKIF11MEN1GAAKMT2A
SCHEMBL24027323 0.78 PKM (0.39) SMN1; SMN2LMNARAB9ANPC1CYP1A2
SCHEMBL20644535 0.77 CACNA1H (0.40) SMN1; SMN2LMNARAB9ANPC1CYP1A2
SCHEMBL5988285 0.73 SMN1; SMN2 (0.43) SMN1; SMN2LMNARAB9ANPC1ALDH1A1
SCHEMBL21611999 0.73 NPC1 (0.38) SMN1; SMN2LMNARAB9ANPC1CYP1A2
SCHEMBL19558098 0.72 ALPL (0.49) SMN1; SMN2LMNARAB9ANPC1CYP2D6
SCHEMBL21035073 0.71 AAK1 (0.48) LMNACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL18888470 0.71 SCN10A (0.33) SMN1; SMN2LMNARAB9ANPC1ALDH1A1
SCHEMBL889358 0.71 HSD17B10 (0.59) SMN1; SMN2LMNARAB9ANPC1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210353606-A1 PqsR INVERSE AGONISTS Helmholtz-Zentrum für Infektionsforschung GmbH (DE) 2021-11-18 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210353606-A1 PqsR INVERSE AGONISTS QRFPR, P2RY11, QARS1 SMN1; SMN2 4555/4885LMNA 4546/4885RAB9A 722/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback